Acute lymphoblastic leukaemia trials in United States
232 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 134
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06698003 - Phase 1Taking peopleStudy of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
- Where
- Cincinnati
- Age
- 1 year to 39 years
- People
- 28
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT06863259 - No phaseTaking peopleExploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study
- Where
- Rochester
- Age
- 2 years to 22 years
- People
- 15
- Run by
- Mayo Clinic
See details and how to joinNCT07071051 - Phase 1Taking peopleThird-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
- Where
- Columbus
- Age
- 18 years and over
- People
- 12
- Run by
- John Reneau
See details and how to joinNCT04848064 - Phase 1Taking peopleA Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 17 years and over
- People
- 18
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06287528 - No phaseTaking peopleAmish/Mennonite Research Contact Registry
- Where
- Pittsburgh
- People
- 1,000
- Run by
- University of Pittsburgh
See details and how to joinNCT02990572 - Phase 1Taking peopleCAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- Where
- Memphis
- Age
- Up to 21 years
- People
- 18
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06326463 - Phase 1Taking peoplePharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
- Where
- Atlanta, New York
- Age
- 12 years and over
- People
- 50
- Run by
- Meryx, Inc.
See details and how to joinNCT04872478 - No phaseTaking peoplePharmacokinetics of Drugs Administered to Children
- Where
- Durham
- Age
- 0 years to 20 years
- People
- 200
- Run by
- Duke University
See details and how to joinNCT03481881 - Phase 2Taking peopleExercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- Where
- Duarte, Memphis, Philadelphia
- Age
- 10 years to 30 years
- People
- 80
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT05194397 - Phase 1Taking peopleCD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
- Where
- Aurora
- Age
- 3 months to 30 years
- People
- 53
- Run by
- University of Colorado, Denver
See details and how to joinNCT06559189 - No phaseTaking peopleFitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
- Where
- Minneapolis
- Age
- 8 years to 25 years
- People
- 90
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05025774 - Phase 1Taking peopleStudy of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- Where
- Atlanta, Augusta, Baltimore, Birmingham, Cleveland, Duarte, Houston, Seattle
- Age
- 18 years and over
- People
- 242 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT04260022 - Phase 1Taking peopleABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
- Where
- Boston, Buffalo, Chicago
- Age
- 18 years and over
- People
- 40
- Run by
- Marlise Luskin, MD
See details and how to joinNCT03595917 - Phase 2Taking peopleTwo Step Haplo With Radiation Conditioning
- Where
- Philadephia
- Age
- 18 years and over
- People
- 63
- Run by
- Thomas Jefferson University
See details and how to joinNCT05031897 - No phaseTaking peopleA Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
- Where
- New York
- Age
- 5 years to 21 years
- People
- 376
- Run by
- Columbia University
See details and how to joinNCT05963971 - Early phase 1Not yet taking people in United StatesSafety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
- Where
- Columbus
- Age
- Up to 30 years
- People
- 12
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05779930 - No phaseTaking peopleInterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- Where
- New York
- Age
- 3 years to 18 years
- People
- 4,900 worldwide
- Run by
- Columbia University
See details and how to joinNCT05929976 - No phaseTaking peopleStudy of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
- Where
- Chicago
- Age
- 18 years to 50 years
- People
- 20
- Run by
- University of Chicago
See details and how to joinNCT06785324 - Phase 2Enrolling by invitationKIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
- Where
- Chicago, Los Angeles, Milwaukee, Nashville, Oakland, Palo Alto, Philadelphia, Salt Lake City, San Diego, San Francisco, Valhalla
- Age
- Up to 21 years
- People
- 50
- Run by
- Michael Pulsipher
See details and how to joinNCT02646839 - Phase 2Taking peopleThe EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- Where
- Atlanta, Aurora, Birmingham, Boston, Buffalo, Charlotte, Duarte, Gainesville, Grand Rapids, Hackensack, Houston, Indianapolis, Kansas City, Los Angeles, Miami, New Haven, Oakland, Phoenix, San Antonio, San Francisco, St. Petersburg, Wilmington
- Age
- 1 year to 25 years
- People
- 95
- Run by
- Pediatric Transplantation & Cellular Therapy Consortium
See details and how to joinNCT03509961 - No phaseTaking peopleUmbilical Vessel Catheterization Under ECG Monitoring and Guidance
- Where
- Palo Alto
- Age
- 1 day to 45 days
- People
- 150
- Run by
- Stanford University
See details and how to joinNCT03898596 - Phase 1Taking peoplePrevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Where
- Boston, Duarte, Minneapolis, New York, Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- Tr1X, Inc.
See details and how to joinNCT06462365 - No phaseTaking peopleBright Ideas - CIN Feasibility Study
- Where
- Falls Church, Los Angeles, New Brunswick
- Age
- 4 years to 18 years
- People
- 75 worldwide
- Run by
- The Hospital for Sick Children
See details and how to joinNCT04929899 - No phaseTaking peopleUsing Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
- Where
- Los Angeles
- Age
- 5 years to 18 years
- People
- 30
- Run by
- Children's Hospital Los Angeles
See details and how to joinNCT06096272